Original Article

Cancer Gene Therapy (2003) 10, 435–444. doi:10.1038/sj.cgt.7700592

Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3

Phuong-Lan Tran1, Jean-Pierre Vigneron2, David Pericat3, Sylvie Dubois4, Dominique Cazals4, Martial Hervy1, Yves A DeClerck5, Claude Degott4 and Christian Auclair1

  1. 1CNRS-UMR 8532, LBPA, Ecole Normale Supérieure, 94235 Cachan, France
  2. 2Chimie des Interactions Moléculaires, Collège de France, 75005 Paris, France
  3. 3Laboratoire d'Expérimentation Animale, Institut Gustave Roussy, 94805 Villejuif, France
  4. 4Laboratoire de Pathologie Cellulaire, Hôpital Beaujon, 92110 Clichy, France
  5. 5Division of Hematology/Oncology, Children's Hospital of Los Angeles, California 90027, USA

Correspondence: Dr Phuong-Lan Tran, UMR 8532 CNRS, Gustave Roussy Institute, 39 rue Camille Desmoulins, 94805 Villejuif cedex, France. E-mail: pltran@igr.fr

Received 5 January 2003.

Top

Abstract

Metalloproteinases (MMPs) and their natural inhibitors (TIMPs) contribute to the regulation of tumor microenvironment. Their expressions are deregulated in almost all human cancers. We report a novel approach to gene therapy of hepatocellular carcinoma (HCC), using repeated injections of DNA plasmids encoding the tissue inhibitors of metalloproteinases (TIMPs) TIMP-2 or TIMP-3, and a novel competent formulation of gene transfer based on nontoxic cationic cholesterol derivatives. The new gene delivery system was efficient in demonstrating the antitumor efficiency of TIMP-2 or TIMP-3 in inhibiting tumor growth of human HuH7 HCC cells xenografted into nude mice. We show, for the first time, an in vivo effect of TIMP-3 in delaying HCC tumor growth. No treatment-related toxicity was noted. An inhibition of angiogenesis and tumor necrosis accompanied the inhibitory effects of TIMP-2 or TIMP-3 on tumor expansion and invasion. We also report a bystander effect produced by transfected HuH7 tumor cells mixed with untransfected cells in 1:1 ratio in culture that resulted in killing 98% of cells within 96 h. In addition, the soluble forms of TIMP-2 and TIMP-3 expressed by transfected cells exerted a cytotoxic effect on untransfected HuH7 cell cultures. Taken together, these results demonstrate the potential efficacy of repeated treatment of secreted TIMP-2 and TIMP-3 for the design of nonviral gene therapy for hepatocarcinoma.

Keywords:

human hepatocellular carcinoma, nonviral gene transfer, tissue inhibitors of metalloproteinases, matrix metalloproteinases, multiple infusions

Extra navigation

.

naturejobs

ADVERTISEMENT